TECHNOLOGY FUNDING MEDICAL PARTNERS I L P
10-Q, EX-27, 2000-11-14
Previous: TECHNOLOGY FUNDING MEDICAL PARTNERS I L P, 10-Q, 2000-11-14
Next: COMPREHENSIVE MEDICAL DIAGNOSTICS GROUP INC, NT 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>6
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE FORM 10-Q AS OF SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS
ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER>1
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-START>                JAN-01-2000
<PERIOD-END>                  SEP-30-2000
<PERIOD-TYPE>                       9-MOS
<INVESTMENTS-AT-COST>           3,360,417
<INVESTMENTS-AT-VALUE>          4,401,378
<RECEIVABLES>                           0
<ASSETS-OTHER>                      1,817
<OTHER-ITEMS-ASSETS>               41,645
<TOTAL-ASSETS>                  4,444,840
<PAYABLE-FOR-SECURITIES>                0
<SENIOR-LONG-TERM-DEBT>                 0
<OTHER-ITEMS-LIABILITIES>         289,943
<TOTAL-LIABILITIES>               289,943
<SENIOR-EQUITY>                         0
<PAID-IN-CAPITAL-COMMON>        3,113,936
<SHARES-COMMON-STOCK>              79,716
<SHARES-COMMON-PRIOR>              79,716
<ACCUMULATED-NII-CURRENT>               0
<OVERDISTRIBUTION-NII>                  0
<ACCUMULATED-NET-GAINS>                 0
<OVERDISTRIBUTION-GAINS>                0
<ACCUM-APPREC-OR-DEPREC>        1,040,961
<NET-ASSETS>                    4,154,897
<DIVIDEND-INCOME>                   8,045
<INTEREST-INCOME>                       0
<OTHER-INCOME>                          0
<EXPENSES-NET>                    395,151
<NET-INVESTMENT-INCOME>          (387,106)
<REALIZED-GAINS-CURRENT>           61,319
<APPREC-INCREASE-CURRENT>      (1,138,468)
<NET-CHANGE-FROM-OPS>          (1,464,255)
<EQUALIZATION>                          0
<DISTRIBUTIONS-OF-INCOME>               0
<DISTRIBUTIONS-OF-GAINS>                0
<DISTRIBUTIONS-OTHER>                   0
<NUMBER-OF-SHARES-SOLD>                 0
<NUMBER-OF-SHARES-REDEEMED>             0
<SHARES-REINVESTED>                     0
<NET-CHANGE-IN-ASSETS>         (1,464,255)
<ACCUMULATED-NII-PRIOR>                 0
<ACCUMULATED-GAINS-PRIOR>               0
<OVERDISTRIB-NII-PRIOR>                 0
<OVERDIST-NET-GAINS-PRIOR>              0
<GROSS-ADVISORY-FEES>             118,947
<INTEREST-EXPENSE>                      0
<GROSS-EXPENSE>                   397,001
<AVERAGE-NET-ASSETS>            4,887,025
<PER-SHARE-NAV-BEGIN>               70.46
<PER-SHARE-NII>                    (18.18)
<PER-SHARE-GAIN-APPREC>                 0
<PER-SHARE-DIVIDEND>                    0
<PER-SHARE-DISTRIBUTIONS>               0
<RETURNS-OF-CAPITAL>                    0
<PER-SHARE-NAV-END>                 52.28
<EXPENSE-RATIO>                      8.09

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission